Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

China flag China · Delayed Price · Currency is CNY
9.39
-0.06 (-0.63%)
At close: Mar 9, 2026
-0.42%
Market Cap 6.21B
Revenue (ttm) 1.47B
Net Income (ttm) -1.00B
Shares Out 661.28M
EPS (ttm) -1.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,186,800
Average Volume 9,208,658
Open 9.51
Previous Close 9.45
Day's Range 9.30 - 9.54
52-Week Range 4.73 - 12.79
Beta 0.57
RSI 47.25
Earnings Date Apr 29, 2026

About Xiangxue Pharmaceutical

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, diet sarsae, juice soda, soymilk, coconut juice, and fruit enzyme; and antiviral oral liquids under the Xiangxue brand name. It also provides medical devices... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1986
Employees 2,769
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300147
Full Company Profile

Financial Performance

In 2024, Xiangxue Pharmaceutical's revenue was 1.86 billion, a decrease of -19.16% compared to the previous year's 2.30 billion. Losses were -858.56 million, 120.7% more than in 2023.

Financial Statements

News

There is no news available yet.